Current management of vaginal dryness
DOI: 10.32364/2618-8430-2021-4-3-250-253
T.V. Tazina1, A.V. Knyazeva2, T.V. Bebneva3,4
1Ryazan State Medical University, Ryazan, Russian Federation
2Regional Clinical Hospital, Ryazan, Russian Federation
3Russian University of Peoples’ Friendship, Moscow, Russian Federation
4National Medical Research Center of Endocrinology, Moscow, Russian Federation
The proportion of women of perimenopausal and postmenopausal age increases every year. Hormonal changes which are typical for these women are characterized by hypoestrogenism and a great diversity of clinical signs, e.g., vaginal dryness, irritation, itching, pain, burning, dyspareunia, and frequent urination. These symptoms occur at any age but are more common in postmenopausal women. Genitourinary syndrome of menopause (GSM) significantly reduces the quality of life of postmenopausal women. Among GSM presentations, vulvovaginal atrophy affects only vulvar and vaginal mucosa. Managing vulvovaginal atrophy in women of various ages is an important issue of gynecological practice. This paper describes current approaches to the treatment for vulvovaginal atrophy in women of various ages with a special focus on the association between vaginal dryness and the reduction of both general and sexual quality of life. In particular, non-hormonal topical medications are discussed. Knowing current (including international) approaches to address vaginal dryness are important for obstetrical gynecological practice.
Keywords: genitourinary syndrome of menopause, vulvovaginal atrophy, lubricants, vaginal moisturizers.
For citation: Tazina T.V., Knyazeva A.V., Bebneva T.V. Current management of vaginal dryness. Russian Journal of Woman and Child Health. 2021;4(3):250–253 (in Russ.). DOI: 10.32364/2618-8430-2021-4-3-250-253.
Acknowledgement
The technical edition is supported by Reckitt.
About the authors:
Tatyana V. Tazina — C. Sc. (Med.), associate professor of the Department of Surgery, Obstetrics, & Gynecology, Ryazan State Medical University; 9, Vysokovol’tnaya str., Ryazan, 390026, Russian Federation; ORCID iD 0000-0003-1029-0390.
Alla V. Knyazeva — Head of Gynecological Department, Regional Clinical Hospital; 1Z, Internatsional’naya str., Ryazan, 390039, Russian Federation; ORCID iD 0000-0003-3436-1843.
Tamara N. Bebneva — C. Sc. (Med.), associate professor of the Department of Obstetrics, Gynecology, & Reproductive Medicine of the Faculty of the Advanced Training of Health Care Workers, Russian University of Peoples’ Friendship; 6, Miklukho-Maklaya str., Moscow, 117198, Russian Federation; physician of the National Medical Research Center of Endocrinology; 11, Dmitriy Ul’yanov str., Moscow, 117036, Russian Federation; ORCID iD 0000-0001-9524-8962.
Contact information: Tatyana V. Tazina, e-mail:
tazina@inbox.ru.
Financial Disclosure: no authors have a financial or property interest in any material or method mentioned.
There is no conflict of interests.
Received 19.07.2021.
Revised 02.08.2021.
Accepted 16.08.2021.
2. Kibrik N.D., Yagubov M.I., Kan I.Yu. Some aspects of the psychopathology of sexual dysfunctions Consilium Medicum. 2019;21(7):25–27 (in Russ.). DOI: 10.26442/20751753.2019.7.190434.
3. Sinha A., Ewies A.A. Non-hormonal topical treatment of vulvovaginal atrophy: an up-to-date overview. Climacteric. 2013;16(3):305–312. DOI: 10.3109/13697137.2012.756466.
4. Griebling T.L., Liao Z., Smith P.G. Systemic and topical hormone therapies reduce vaginal innervation density in postmenopausal women. Menopause. 2012;19:630–635. DOI: 10.1097/gme.0b013e31823b8983.
5. Frank S.M., Ziegler C., Kokot-Kierepa M. et al. Vaginal Health: Insights, Views and Attitudes (VIVA) survey — Canadian cohort. Menopause Int. 2013;19(1):20–27. DOI: 10.1258/mi.2012.012034.
6. Pastore L.M., Carter R.A., Hulka B.S., Wells E. Self-reported urogenital symptoms in postmenopausal women: Women’s Health Initiative. Maturitas. 2004;49(4):292–303. DOI: 10.1016/j.maturitas.2004.06.019.
7. Sycheva E.G., Apolikhina I.A. Correction of estrogen-deficient states in women with urogenital disorders. Akusherstvo i ginekologiya. 2015;4:75–79 (in Russ.).
8. Castelo-Branco C., Cancelo M.J., Villero J. et al. Management of post-menopausal vaginal atrophy and atrophic vaginitis. Maturitas. 2005;52(Suppl 1):S46–52. DOI: 10.1016/j.maturitas.2005.06.014.
9. Rogovskaya S.I. Practical colposcopy. Monograph. 3rd ed., Rev., Add. M.: GEOTAR-Media; 2012 (in Russ.).
10. Balan V.E., Kovaleva L.A. Complex treatment of urogenital atrophy and recurrent urinary tract infections in postmenopausal women. Effective pharmacotherapy. Akusherstvo i ginekologiya. 2013;2:18 (in Russ.).
11. Prilepskaya V.N., ed. Manual on contraception. M.: MEDpress-inform, 2010 (in Russ.).
12. The 2020 genitourinary syndrome of menopause position statement of The North American Menopause Society, Menopause. 2020;27(Issue 9):976–992. DOI: 10.1097/GME.0000000000001609.
13. Edwards D., Panay N. Treating vulvovaginal atrophy/genitourinary syndrome of menopause: how important is vaginal lubricant and moisturizer composition? Climacteric. 2016;19(2):151–161. DOI: 10.3109/13697137.2015.1124259.
14. Maniglio P., Ricciardi E., Meli F. et al. A pilot study of soft gel technology: a new vaginal device to improve the symptomatology of vulvovaginal atrophy in post-partum, menopause and in patients with recurrent vulvovaginitis. Eur Rev Med Pharmacol Sci. 2019;23(14):6035–6044. DOI: 10.26355/eurrev_201907_18416.
15. Herbenick D, Reece M, Hensel D, Sanders S, Jozkowski K, Fortenberry JD. Association of lubricant use with women's sexual pleasure, sexual satisfaction, and genital symptoms: a prospective daily diary study. J Sex Med. 2011;8(1):202–212. doi: 10.1111/j.1743-6109.2010.02067.x.
16. Lee Y.K., Chung H.H., Kim J.W. et al. Vaginal pH-balanced gel for the control of atrophic vaginitis among breast cancer survivors: a randomized controlled trial. Obstet Gynecol. 2011;117(4):922–927. DOI: 10.1097/AOG.0b013e3182118790.
17. Menopausal hormone therapy and maintaining the health of women in adulthood. Clinical guidelines (treatment protocol). M.; 2015 (in Russ.).
This work is licensed under a Creative Commons «Attribution» 4.0 License.
Распечатать